{"id":"https://openalex.org/W4379280741","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.12027","title":"Use of clinical pathways to identify patients with cancer who may benefit from serious illness conversations.","display_name":"Use of clinical pathways to identify patients with cancer who may benefit from serious illness conversations.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379280741","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.12027"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.12027","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.12027","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060923327","display_name":"Cody E. Cotner","orcid":"https://orcid.org/0000-0003-2147-972X","observed_orcids":["https://orcid.org/0000-0003-2147-972X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cody E Cotner","raw_affiliation_strings":["Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042995297","display_name":"Angela C. Tramontano","orcid":"https://orcid.org/0000-0001-5718-6297","observed_orcids":["https://orcid.org/0000-0001-5718-6297"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Tramontano","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110519","display_name":"David Michael Jackman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Michael Jackman","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014360467","display_name":"James A. Tulsky","orcid":"https://orcid.org/0000-0002-7458-0453","observed_orcids":["https://orcid.org/0000-0002-7458-0453"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Tulsky","raw_affiliation_strings":["Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037393862","display_name":"Joseph O. Jacobson","orcid":"https://orcid.org/0000-0001-8634-5891","observed_orcids":["https://orcid.org/0000-0001-8634-5891"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Jacobson","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Rice","raw_affiliation_strings":["Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080245573","display_name":"Alex Post","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Post","raw_affiliation_strings":["Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113997696","display_name":"Brian Finn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Finn","raw_affiliation_strings":["Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053657758","display_name":"Sishemo Mwesigwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sishemo Mwesigwa","raw_affiliation_strings":["Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028800667","display_name":"Charlotta J. Lindvall","orcid":"https://orcid.org/0000-0003-2090-2039","observed_orcids":["https://orcid.org/0000-0003-2090-2039"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charlotta Lindvall","raw_affiliation_strings":["Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032378308","display_name":"Alexi A. Wright","orcid":"https://orcid.org/0000-0002-9776-7114","observed_orcids":["https://orcid.org/0000-0002-9776-7114"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexi A. Wright","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045235614","display_name":"Christopher R. Manz","orcid":"https://orcid.org/0000-0003-0928-3492","observed_orcids":["https://orcid.org/0000-0003-0928-3492"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Manz","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"12027","last_page":"12027"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13340","display_name":"Palliative and Oncologic Care","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10350","display_name":"Electronic Health Records Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/care-pathways","display_name":"care pathways","score":0.8759999871253967},{"id":"https://openalex.org/keywords/serious-illness-conversations","display_name":"serious illness conversations","score":0.9959999918937683},{"id":"https://openalex.org/keywords/advance-care-planning","display_name":"advance care planning","score":0.9869999885559082},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/poor-prognosis","display_name":"poor prognosis","score":0.7990000247955322},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7239999771118164},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.3790000081062317},{"id":"https://openalex.org/keywords/goal-concordant-care","display_name":"goal-concordant care","score":0.796999990940094},{"id":"https://openalex.org/keywords/patient-identification","display_name":"patient identification","score":0.3109999895095825},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.6010000109672546},{"id":"https://openalex.org/keywords/quality-of-cancer-care","display_name":"quality of cancer care","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.937993049621582},{"id":"https://openalex.org/C2780642338","wikidata":"https://www.wikidata.org/wiki/Q7632042","display_name":"Subspecialty","level":2,"score":0.6301587820053101},{"id":"https://openalex.org/C2994302464","wikidata":"https://www.wikidata.org/wiki/Q1774706","display_name":"Care pathway","level":3,"score":0.618772566318512},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.5531179904937744},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5375617742538452},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.5341554880142212},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5330385565757751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46820929646492004},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4398021101951599},{"id":"https://openalex.org/C2778373050","wikidata":"https://www.wikidata.org/wiki/Q1774706","display_name":"Clinical pathway","level":2,"score":0.4179803133010864},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.31938087940216064},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.24004784226417542},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12551391124725342},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.08680132031440735},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.12027","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.12027","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402969429","https://openalex.org/W3201193189","https://openalex.org/W4286298910","https://openalex.org/W4410815449","https://openalex.org/W3199667245","https://openalex.org/W4402985418","https://openalex.org/W7221656931","https://openalex.org/W3001759323","https://openalex.org/W3029860990","https://openalex.org/W4402984987"],"abstract_inverted_index":{"12027":[0],"Background:":[1],"Treatment":[2],"pathways":[3,32,70,332,394],"are":[4],"widely":[5],"used":[6,19,335],"to":[7,20,26,52,71,138,260,340,386,395,400],"provide":[8],"decision":[9],"support":[10],"and":[11,97,154,178,208,218,246,276,318,347,368,397],"encourage":[12],"guideline":[13],"adherence.":[14],"Pathways":[15],"data":[16,33,137],"may":[17,34],"be":[18,50,103,334],"identify":[21,139,341,396],"patients":[22,39,58,89,116,174,182,197,229,249,279,288,299,342,356],"for":[23,43,88,98,108,115,195,223,311,320],"targeted":[24],"interventions":[25,399],"improve":[27,387],"cancer":[28],"care.":[29,55,389],"For":[30,57,161,256],"example,":[31],"enable":[35],"the":[36,73,166,171,179,187,235,264,270,283,380],"identification":[37],"of":[38,75,93,151,157,173,181,248,278,287,298,355,371,382],"with":[40,90,117,122,133,175,343],"poor":[41,123,232,261,293,315,327,348,360,376],"prognoses":[42],"whom":[44,99],"serious":[45],"illness":[46],"conversations":[47],"(SICs)":[48],"should":[49],"prioritized":[51],"ensure":[53],"goal-concordant":[54],"Methods:":[56],"starting":[59],"new":[60],"therapies":[61,87],"at":[62,303],"Dana-Farber,":[63],"oncologists":[64,78],"select":[65],"a":[66,253,292,314,326,337,359,375],"node":[67,113,362],"in":[68,83,142,226],"clinical":[69,391],"indicate":[72],"line":[74],"treatment.":[76],"Subspecialty":[77],"identified":[79],"\u201cpoor":[80],"prognosis\u201d":[81],"nodes":[82,125,257],"pathways,":[84],"defined":[85],"as":[86,336],"expected":[91],"survivals":[92],"<":[94],"12":[95],"months":[96,150],"an":[100,143,176,301,364],"SIC":[101,140,219,242,272,302,365],"would":[102],"appropriate":[104],"(e.g.,":[105],"3rd-line":[106],"treatment":[107,212],"metastatic":[109,118,344],"colon":[110],"cancer).":[111],"Pathway":[112],"navigations":[114,194],"solid":[119,345],"tumor":[120],"malignancies":[121],"prognosis":[124,233,262,294,316,328,361,377],"(n":[126],"=":[127],"21":[128],"disease":[129],"pathways)":[130],"were":[131,192],"combined":[132],"electronic":[134],"medical":[135],"record":[136],"documentation":[141],"advance":[144],"care":[145],"planning":[146],"module":[147],"within":[148],"6":[149],"pathway":[152],"navigation":[153],"patients\u2019":[155,214],"dates":[156],"death":[158,304,367],"if":[159],"present.":[160],"each":[162,211],"node,":[163,317,378],"we":[164],"calculated":[165],"median":[167,215,236,265],"overall":[168],"survival":[169],"(OS),":[170],"proportion":[172,180,297],"SIC,":[177],"who":[183,230,322,357],"died":[184,250,280,289],"before":[185,366],"reaching":[186,252,282,291,313],"next":[188,284],"node.":[189,255,285,295,329],"Results:":[190],"There":[191],"10,132":[193],"7,031":[196],"(median":[198],"age":[199],"67":[200],"years,":[201],"52%":[202],"female,":[203],"86%":[204],"White)":[205],"between":[206],"8/16/2019":[207],"1/4/2023.":[209],"With":[210],"line,":[213],"OS":[216,237,266],"decreased":[217],"rates":[220],"increased":[221],"(examples":[222],"3":[224],"diseases":[225],"Table).":[227],"Among":[228],"reached":[231,358,374],"nodes,":[234,263],"was":[238,244,267,274,305],"4.9":[239],"months,":[240,269],"mean":[241,271],"rate":[243,273],"43.8%,":[245],"60.2%":[247],"without":[251,281,290],"subsequent":[254],"immediately":[258],"prior":[259],"7.1":[268],"25.2%,":[275],"31.3%":[277],"46.3%":[286],"The":[296],"having":[300],"40.9%":[306],"among":[307],"all":[308],"decedents,":[309],"50.8%":[310],"decedents":[312,321,372],"29.3%":[319],"do":[323],"not":[324],"reach":[325],"Conclusions:":[330],"Clinical":[331],"can":[333],"scalable":[338],"method":[339],"tumors":[346],"prognoses.":[349],"In":[350],"our":[351],"study,":[352],"only":[353],"half":[354,370],"had":[363],"nearly":[369],"never":[373],"underscoring":[379],"importance":[381],"identifying":[383],"this":[384],"population":[385],"end-of-life":[388],"A":[390],"trial":[392],"using":[393],"deliver":[398],"increase":[401],"SICs":[402],"is":[403],"ongoing.":[404],"[Table:":[405],"see":[406],"text]":[407]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2023-06-05T00:00:00"}